These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29725421)

  • 1. Expression of Bcl-2 is a favorable prognostic biomarker in lung squamous cell carcinoma.
    Feng C; Wu J; Yang F; Qiu M; Hu S; Guo S; Wu J; Ying X; Wang J
    Oncol Lett; 2018 May; 15(5):6925-6930. PubMed ID: 29725421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skp2 expression has different clinicopathological and prognostic implications in lung adenocarcinoma and squamous cell carcinoma.
    Zhong K; Yang F; Han Q; Chen J; Wang J
    Oncol Lett; 2018 Sep; 16(3):2873-2880. PubMed ID: 30127874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic analysis of apoptosis-related genes in the prognosis of lung squamous cell carcinoma: a combined single-cell RNA sequencing study.
    Zhu P; Yang W; Wang B; Zeng T; Hu Z; Zhang D; Yang Z; Wang K; Pu J
    J Thorac Dis; 2023 Dec; 15(12):6946-6966. PubMed ID: 38249925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of IL-6R mRNA in lung adenocarcinoma and squamous cell carcinoma.
    Xu B; Chen Q; Yue C; Lan L; Jiang J; Shen Y; Lu B
    Oncol Lett; 2018 Sep; 16(3):2935-2948. PubMed ID: 30127882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Survival-Associated Alternative Splicing Signatures in Lung Squamous Cell Carcinoma.
    Liu Y; Jia W; Li J; Zhu H; Yu J
    Front Oncol; 2020; 10():587343. PubMed ID: 33117720
    [No Abstract]   [Full Text] [Related]  

  • 6. Integrated analysis of competing endogenous RNA network revealing lncRNAs as potential prognostic biomarkers in human lung squamous cell carcinoma.
    Sui J; Xu SY; Han J; Yang SR; Li CY; Yin LH; Pu YP; Liang GY
    Oncotarget; 2017 Sep; 8(39):65997-66018. PubMed ID: 29029488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of seven-gene signature for prediction of lung squamous cell carcinoma.
    Wang Z; Wang Z; Niu X; Liu J; Wang Z; Chen L; Qin B
    Onco Targets Ther; 2019; 12():5979-5988. PubMed ID: 31440059
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
    Liu X; Chen L; Zhang T
    Cancer Control; 2018; 25(1):1073274818778001. PubMed ID: 29843532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and validation of a seven-microRNA signature as a prognostic tool for lung squamous cell carcinoma.
    Gan Z; Zou Q; Lin Y; Huang X; Huang Z; Chen Z; Xu Z; Lv Y
    Cancer Manag Res; 2019; 11():5701-5709. PubMed ID: 31417313
    [No Abstract]   [Full Text] [Related]  

  • 10. High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma.
    Zhou S; Wang P; Su X; Chen J; Chen H; Yang H; Fang A; Xie L; Yao Y; Yang J
    PLoS One; 2017; 12(10):e0187356. PubMed ID: 29088286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC.
    Fu L; Wang H; Wei D; Wang B; Zhang C; Zhu T; Ma Z; Li Z; Wu Y; Yu G
    PLoS One; 2020; 15(5):e0233283. PubMed ID: 32437446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
    Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
    World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of miR-486-5p and its significance in lung squamous cell carcinoma.
    Yang S; Sui J; Liu T; Wu W; Xu S; Yin L; Pu Y; Zhang X; Zhang Y; Shen B; Liang G
    J Cell Biochem; 2019 Aug; 120(8):13912-13923. PubMed ID: 30963622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomere-associated genes and telomeric lncRNAs are biomarker candidates in lung squamous cell carcinoma (LUSC).
    Storti CB; de Oliveira RA; de Carvalho M; Hasimoto EN; Cataneo DC; Cataneo AJM; De Faveri J; Vasconcelos EJR; Dos Reis PP; Cano MIN
    Exp Mol Pathol; 2020 Feb; 112():104354. PubMed ID: 31837325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of 17 mRNAs and a miRNA as an integrated prognostic signature for lung squamous cell carcinoma.
    Zhang J; Bing Z; Yan P; Tian J; Shi X; Wang Y; Yang K
    J Gene Med; 2019 Aug; 21(8):e3105. PubMed ID: 31215090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a seven-miRNA signature as prognostic biomarker for lung squamous cell carcinoma.
    Gao X; Wu Y; Yu W; Li H
    Oncotarget; 2016 Dec; 7(49):81670-81679. PubMed ID: 27835574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Indication of Poor Prognosis by High Expression of ENO1 in Squamous Cell Carcinoma of the Lung.
    Huang WY; Chen G; Chen SW; Dang YW; Deng Y; Zhou HF; Kong JL; Zhang Y; Mo JX; Li CB; He J
    J Oncol; 2021; 2021():9910962. PubMed ID: 34504528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical value of miR-182-5p in lung squamous cell carcinoma: a study combining data from TCGA, GEO, and RT-qPCR validation.
    Luo J; Shi K; Yin SY; Tang RX; Chen WJ; Huang LZ; Gan TQ; Cai ZW; Chen G
    World J Surg Oncol; 2018 Apr; 16(1):76. PubMed ID: 29636077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of aberrantly expressed methylation gene profiles in lung squamous cell carcinoma: A study based on The Cancer Genome Atlas.
    Gao C; Zhuang J; Zhou C; Ma K; Zhao M; Liu C; Liu L; Li H; Feng F; Sun C
    J Cell Physiol; 2019 May; 234(5):6519-6528. PubMed ID: 30246311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GABRP is a Promising Prognostic Biomarker and Associated with Immune Cell Infiltration in Lung Squamous Cell Carcinoma.
    Fu J; Lin J; Zeng X; Li G; Wei Y; Xian L
    Pharmgenomics Pers Med; 2023; 16():357-371. PubMed ID: 37091829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.